1 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 3, 1 Early Phase 1, 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Early Phase 1 | 1 | Not yet recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Chemotherapy Regimen: new trials by email Literature Review of Chemotherapy Regimen trials Research Report on Chemotherapy Regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma Resection of PET (high) and PET (low) Tumors, Lifileucel Manufacturing Clinical v Research, Chemotherapy Regimen - Unresectable or Metastatic Melanoma | Early Phase 1 | Not yet recruiting | Abramson Cancer Center at Penn Medicine | 10 | 2026-10-01 | 2026-07-13 |
| ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL Olverembatinib, Gecacitinib, Venetoclax - Ph-Like, Acute Lymphoblastic Leukemia | Not applicable | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 92 | 2026-05-30 | 2026-05-13 |
| A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias Revumenib, Chemotherapy Regimen, HiDAC - Acute Myeloid Leukemias | Phase 1 | Active not recruiting | Syndax Pharmaceuticals | 96 | 2024-05-21 | 2026-09-16 |
| Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCT Demethylation drug, Chemotherapy regimen - Myelodysplastic Syndrome, Chemotherapy | Unknown | Nanfang Hospital, Southern Medical University | 250 | 2016-07-01 | 2017-12-08 | |
| Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) Photodynamic therapy-Photofrin, Stenting procedure, Chemotherapy regimen - Hilar Cholangiocarcinoma | Phase 3 | Terminated | Concordia Laboratories Inc. | 28 | 2014-11-12 | 2019-08-28 |
| Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel Balugrastim, Pegfilgrastim, Chemotherapy Regimen - Chemotherapy-induced Neutropenia | Phase 2 / Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 334 | 2008-08-21 | 2024-04-03 |
Bile Duct Neoplasms (1) · Cholangiocarcinoma (1) · Klatskin Tumor (1) · Leukemia, Myeloid, Acute (1) · Melanoma (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Abramson Cancer Center at Penn Medicine (1) · Concordia Laboratories Inc. (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Nanfang Hospital, Southern Medical University (1) · Syndax Pharmaceuticals (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1)
United States (3) · Canada (2) · China (2) · Australia (1) · Germany (1) · Netherlands (1) · South Korea (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Michel Kahaleh, MD (1) · Qifa Liu (1) · Ravi Amaravadi, MD (1)